Key Details
Price
$1.03Annual ROE
-31.90%Beta
0.41Events Calendar
Next earnings date:
Mar 5, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Apr 7, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 9, 2022Analyst ratings
Recent major analysts updates
Aug 17, 23 Cantor Fitzgerald
NeutralJul 13, 22 Cantor Fitzgerald
NeutralJun 7, 22 HC Wainwright & Co.
NeutralMay 6, 22 Cantor Fitzgerald
NeutralMar 11, 22 HC Wainwright & Co.
BuyNov 12, 21 HC Wainwright & Co.
BuyAug 7, 20 Jefferies
UnderperformMay 19, 20 JP Morgan
NeutralMay 7, 20 H.C. Wainwright
BuyApr 16, 20 Stifel
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
TherapeuticsMD doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TXMD
benzinga.comAugust 26, 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
TXMD
Zacks Investment ResearchApril 14, 2023
TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FAQ
- What is the ticker symbol for TherapeuticsMD?
- Does TherapeuticsMD pay dividends?
- What sector is TherapeuticsMD in?
- What industry is TherapeuticsMD in?
- What country is TherapeuticsMD based in?
- When did TherapeuticsMD go public?
- Is TherapeuticsMD in the S&P 500?
- Is TherapeuticsMD in the NASDAQ 100?
- Is TherapeuticsMD in the Dow Jones?
- When was TherapeuticsMD's last earnings report?
- When does TherapeuticsMD report earnings?
- Should I buy TherapeuticsMD stock now?
What is the ticker symbol for TherapeuticsMD?
The ticker symbol for TherapeuticsMD is NASDAQ:TXMD
Does TherapeuticsMD pay dividends?
No, TherapeuticsMD does not pay dividends
What sector is TherapeuticsMD in?
TherapeuticsMD is in the Healthcare sector
What industry is TherapeuticsMD in?
TherapeuticsMD is in the Drug Manufacturers - Specialty & Generic industry
What country is TherapeuticsMD based in?
TherapeuticsMD is headquartered in United States
When did TherapeuticsMD go public?
TherapeuticsMD's initial public offering (IPO) was on May 9, 2007
Is TherapeuticsMD in the S&P 500?
No, TherapeuticsMD is not included in the S&P 500 index
Is TherapeuticsMD in the NASDAQ 100?
No, TherapeuticsMD is not included in the NASDAQ 100 index
Is TherapeuticsMD in the Dow Jones?
No, TherapeuticsMD is not included in the Dow Jones index
When was TherapeuticsMD's last earnings report?
TherapeuticsMD's most recent earnings report was on Nov 12, 2024
When does TherapeuticsMD report earnings?
The next expected earnings date for TherapeuticsMD is Mar 5, 2025
Should I buy TherapeuticsMD stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions